The new consent principles are designed to raise awareness of what informed consent means and place patients at the heart of decision-making about their treatment
A groundbreaking genetic point-of-care test designed to prevent avoidable hearing loss in newborn babies is being rolled out across Scotland, and IBMS Fellow Ryan Cooper has played a key role in making it a reality.
IBMS Council member Charlie Houston FIBMS CSci MSc has held key leadership positions, including Chief Biomedical Scientist, Biochemistry Laboratory Manager, and POCT Coordinator.